Clinical trial
Alternative Schedule of Velcade/Dexamethasone Plus Doxil for Patients With…
NCT00366106 · Accelerated Community Oncology Research Network, Other · Terminated
Key facts
| NCT number | NCT00366106 |
|---|---|
| Title | Alternative Schedule of Velcade/Dexamethasone Plus Doxil for Patients With Multiple Myeloma |
| Official title | A Phase II, Open Label Study Evaluating an Alternative Schedule of Velcade/Dexamethasone Plus Doxil in the Treatment of Multiple Myeloma |
| Lead sponsor | Accelerated Community Oncology Research Network, Other |
| Collaborators | Millennium Pharmaceuticals, Inc. Industry |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Multiple Myeloma |
| Intervention type | Drug |
| Interventions | bortezomib, dexamethasone, doxorubicin HCl liposome |
| Enrollment | 32 |
| Start date | Jul 1, 2006 |
| Primary completion | Mar 1, 2011 |
| Completion | Mar 1, 2011 |
| First posted | Aug 18, 2006 |
| Last update posted | Apr 6, 2012 |
| Countries | United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: